Thomas C. Reynolds

Chief Medical Officer, Seagen.

Companies

Lite Strategy, Inc.Board member Feb 11, 2013 to now¹
Trillium Therapeutics Inc.Board member Jan 4, 2021 to Jan 4, 2021²
SeagenChief Medical Officer Mar 21, 2007 to Jan 29, 2013³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lite Strategy, Inc. LITS500 shares⁴$580 at $1.16Jul 17, 2025

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLite Strategy, Inc., Board member
2
SEC EDGARTrillium Therapeutics Inc., Board member
3
SEC EDGARSeagen, Chief Medical Officer
4
SEC EDGARLite Strategy, Inc. shares after the filing of Jul 17, 2025